Prolifera, a protein integral to cellular growth, proliferation, and stress response, is regulated and activated by a series of chemical compounds through intricate biochemical pathways. Compounds such as Forskolin and Thapsigargin play a crucial role in this activation. Forskolin, by raising intracellular cAMP levels, indirectly activates Prolifera through PKA-mediated phosphorylation pathways, enhancing its role in cellular differentiation and proliferation. Similarly, Thapsigargin, by elevating intracellular calcium levels, activates calcium-dependent signaling pathways, thereby augmenting Prolifera's involvement in stress response and apoptosis. Additionally, compounds like Epigallocatechin gallate (EGCG) and Resveratrol exert their effects through kinase inhibition and antioxidant properties, respectively. EGCG, by inhibiting competing kinases, indirectly upregulates pathways where Prolifera is active, especially in growth and stress response mechanisms. Resveratrol, through its influence on oxidative stress pathways, also indirectly enhances Prolifera's functional role in cellular defense.
Furthermore, the modulation of specific kinase pathways by inhibitors such as LY294002, Wortmannin, PD98059, and U0126 plays a significant role in the functional enhancement of Prolifera. LY294002 and Wortmannin, as PI3K inhibitors, indirectly elevate Prolifera's activity in cell survival and metabolic pathways. PD98059 and U0126, both MEK inhibitors, impact the MAPK/ERK pathway, promoting Prolifera's involvement in cell growth and differentiation. Additionally, Phorbol 12-myristate 13-acetate (PMA) and Sphingosine-1-phosphate, through PKC activation and lipid signaling modulation respectively, contribute to Prolifera's activation in differentiation and proliferation processes. SB203580, by inhibiting p38 MAPK, shifts the signaling equilibrium, further facilitating Prolifera's role in stress response and inflammatory pathways. Rapamycin, an mTOR inhibitor, complements this array of activators by affecting cell growth and metabolism, indirectly enhancing Prolifera's functional activity in cell cycle progression. Collectively, these activators, through their targeted effects on cellular signaling, intricately enhance the functional activity of Prolifera, pivotal in key cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, activating protein kinase A (PKA). PKA-mediated phosphorylation pathways are then enhanced, leading to an indirect augmentation of Prolifera's role in cellular differentiation and proliferation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG, a kinase inhibitor, indirectly upregulates pathways where Prolifera is active by inhibiting competing kinases, thereby enhancing Prolifera’s role in growth and stress response. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
As a PI3K inhibitor, LY294002 modulates the PI3K/AKT pathway, indirectly enhancing the activity of Prolifera in cell survival and metabolic pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), influencing multiple signaling pathways. This activation leads to an indirect enhancement of Prolifera's functional activity in cellular differentiation and proliferation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol influences signaling pathways involving oxidative stress response, indirectly enhancing Prolifera’s activity in cellular defense mechanisms. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
This compound modulates lipid signaling pathways, indirectly influencing Prolifera’s role in cellular proliferation and differentiation processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, a MEK inhibitor, impacts the MAPK/ERK pathway, indirectly enhancing Prolifera’s activity in cell growth and differentiation processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, altering MAPK signaling balance and indirectly enhancing Prolifera's functional activity in stress response and inflammatory pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin increases intracellular calcium levels, activating calcium-dependent signaling pathways and enhancing Prolifera’s activity in stress response and apoptosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
As a PI3K inhibitor, Wortmannin indirectly enhances the functional activity of Prolifera by modulating cell survival and metabolism pathways. | ||||||